Table 5.
Categorical comparison of significant post-diagnosis weight loss incidence (in patients without cachexia at diagnosis) between prior medication use groups and anti-inflammatory medication null patients.
Prior medication use category (N) | Patients that reached significant weight loss within 6 months of cancer diagnosis (%) | P-value |
---|---|---|
No anti-inflammatory medication (1517) | 638 (42.06%) | |
Medication groups | ||
Any glucocorticoid (228) | 118 (51.75%) | 0.0059 |
Any NSAID (355) | 185 (52.11%) | 0.0006 |
Low-dose aspirin (224) | 113 (50.45%) | 0.0180 |
Other nonselective NSAIDs (115) | 58 (50.43%) | 0.0799 |
Selective COX-2 inhibitors (91) | 53 (58.24%) | 0.0025 |
P values bolded if <0.05.